Recent findings by the US FDA link weight loss medications, such as Wegovy, Ozempic, and Mounjaro, to an increased risk of suicidal thoughts. These drugs might affect the brain’s chemistry, potentially contributing to depressive symptoms. The findings emphasize the importance of actively monitoring mental health when using these medications, understanding the risks, and promoting open discussions about the potential impacts of these drugs on mental health. Increased awareness and open conversations about mental health are key to suicide prevention.
